Citigroup
NTUS

Citigroup’s Natus Medical Inc NTUS Stock Holding History

Citigroup’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-20,000
Closed -$696K – 7400
2016
Q4 		$696K Buy
+20,000
New +$785K ﹤0.01% 4039

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citigroup's NTUS Position: Q3 2022 in Review

Citigroup sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 117,425 shares — an estimated $3.85M sold.

Citigroup first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $3.85M in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Citigroup reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Citigroup sold 117,425 Natus Medical Inc shares in Q3 2022, an estimated $3.85M.
  • Citigroup first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
  • Citigroup's Natus Medical Inc position peaked at $3.85M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.